Pharmaceuticals company Trident Lifeline (BOM:543616) has completed the acquisition of an additional 50.49% of TLL Parenterals via the allotment of equity shares to make it a subsidiary, according to a Monday filing to the BSE.
In November, the company agreed to acquire 1,122,000 equity shares of 10 Indian rupees in the chemical and pharmaceutical manufacturer for a total price of 11.2 million rupees.
Price (INR): ₹291.75, Change: ₹+3.8, Percent Change: +1.30%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。